These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1333 related items for PubMed ID: 19027486

  • 1. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS, Choi JR, Yoon SH, Song J, Kim J, Kim SJ, Kwon O, Min YH.
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [Abstract] [Full Text] [Related]

  • 2. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D.
    Cancer; 2006 Apr 15; 106(8):1730-8. PubMed ID: 16532439
    [Abstract] [Full Text] [Related]

  • 3. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
    Bacher U, Schnittger S, Kern W, Trenn G, Weisser M, Haferlach T, Schoch C.
    Cancer Genet Cytogenet; 2006 Jul 15; 168(2):172-4. PubMed ID: 16843110
    [Abstract] [Full Text] [Related]

  • 4. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F, Pisegna S, Diverio D.
    Haematologica; 1997 Jul 15; 82(3):364-70. PubMed ID: 9234595
    [Abstract] [Full Text] [Related]

  • 5. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
    Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M.
    Genes Chromosomes Cancer; 2005 Nov 15; 44(3):265-70. PubMed ID: 16015645
    [Abstract] [Full Text] [Related]

  • 6. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
    Cuenco GM, Ren R.
    Oncogene; 2004 Jan 15; 23(2):569-79. PubMed ID: 14724585
    [Abstract] [Full Text] [Related]

  • 7. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis].
    Liu XP, Zhang MR, Dai Y, Zhang L, Li R, Hao YS, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 15; 27(5):310-3. PubMed ID: 16875579
    [Abstract] [Full Text] [Related]

  • 8. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD, Castro J, Fernández AC, López-Enríquez A, Fradera J, Pacheco E.
    P R Health Sci J; 2009 Jun 15; 28(2):146-50. PubMed ID: 19530558
    [Abstract] [Full Text] [Related]

  • 9. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C, Rowley JD, Nucifora G.
    Leukemia; 1997 Apr 15; 11 Suppl 3():273-8. PubMed ID: 9209363
    [Abstract] [Full Text] [Related]

  • 10. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
    García-Casado Z, Cervera J, Valencia A, Pajuelo JC, Mena-Duran AV, Barragán E, Bolufer P, Sanz MA.
    Cancer Genet Cytogenet; 2006 Jul 01; 168(1):73-6. PubMed ID: 16772124
    [Abstract] [Full Text] [Related]

  • 11. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Van Dyke DL, Wiktor A, Rowley JD.
    Genes Chromosomes Cancer; 2004 Aug 01; 40(4):365-70. PubMed ID: 15188461
    [Abstract] [Full Text] [Related]

  • 12. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C, Bacher U, Grossmann V, Schindela S, Zenger M, Kohlmann A, Kern W, Haferlach T, Schnittger S.
    Genes Chromosomes Cancer; 2012 Dec 01; 51(12):1079-85. PubMed ID: 22887804
    [Abstract] [Full Text] [Related]

  • 13. Complex t(8;13;21)(q22;q14;q22)--a novel variant of t(8;21) in a patient with acute myeloid leukemia (AML-M2).
    Udayakumar AM, Alkindi S, Pathare AV, Raeburn JA.
    Arch Med Res; 2008 Feb 01; 39(2):252-6. PubMed ID: 18164974
    [Abstract] [Full Text] [Related]

  • 14. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G.
    Haematologica; 1999 Nov 01; 84(11):963-8. PubMed ID: 10553155
    [Abstract] [Full Text] [Related]

  • 15. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S, Gröschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL, Jan Ossenkoppele G, Vellenga E, van den Berg-de Ruiter E, Schanz U, Verhoef G, Vandenberghe P, Ferrant A, Köhne CH, Pfreundschuh M, Horst HA, Koller E, von Lilienfeld-Toal M, Bentz M, Ganser A, Schlegelberger B, Jotterand M, Krauter J, Pabst T, Theobald M, Schlenk RF, Delwel R, Döhner K, Löwenberg B, Döhner H.
    J Clin Oncol; 2010 Aug 20; 28(24):3890-8. PubMed ID: 20660833
    [Abstract] [Full Text] [Related]

  • 16. [Detection of t(3 ; 21) (q26 ; q22) with AML1/EVI1 mRNA during progression of myelodysplastic syndrome to acute myeloid leukemia].
    Choi I, Goto T, Nagano M, Muta K, Yufu Y, Uike N, Kozuru M, Abe Y, Nisimura J.
    Rinsho Ketsueki; 1999 Jun 20; 40(6):518-20. PubMed ID: 10422292
    [Abstract] [Full Text] [Related]

  • 17. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML.
    Cuenco GM, Nucifora G, Ren R.
    Proc Natl Acad Sci U S A; 2000 Feb 15; 97(4):1760-5. PubMed ID: 10677531
    [Abstract] [Full Text] [Related]

  • 18. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C, Hayes LA, He SZ, Quach H, McQuilten ZK, Wall M, Campbell LJ.
    Am J Hematol; 2009 Nov 15; 84(11):715-9. PubMed ID: 19806661
    [Abstract] [Full Text] [Related]

  • 19. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S, Mellink CH, van der Lelie H.
    Cancer Genet Cytogenet; 2008 Jan 15; 180(2):149-52. PubMed ID: 18206542
    [Abstract] [Full Text] [Related]

  • 20. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
    Cuenco GM, Ren R.
    Oncogene; 2001 Dec 13; 20(57):8236-48. PubMed ID: 11781838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.